|
|
CTD2932
|
NATRIXAM TABLETS 1.5MG/5MG
|
INDAPAMIDE, AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2015/CTD2931/565/R1
|
Natrixam Tablets 1.5mg/10mg
|
Indapamide/Amlodipine
|
LES LABORATORIES SERVIER 905 ROUTE DE SARAN,…
|
Retained
|
Details →
|
|
|
H2022/CTD8175/17817
|
EUVASCOR® 40 MG/5 MG
|
ATORVASTATIN / PERINDOPRIL ARGININE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
21829
|
COVERAM 10/10MG
|
PERINDOPRIL ARGININE/AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
21830
|
COVERAM 10/5MG
|
PERINDOPRIL ARGININE/AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
21831
|
COVERAM 5/10MG
|
PERINDOPRIL ARGININE/AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
21832
|
COVERAM 5/5MG
|
PERINDOPRIL ARGININE/AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
CTD3096
|
TRIPLIXAM 10/2.5/10MG
|
PERINDOPRIL ARGININE/INDAPAMINE/AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
CTD3095
|
TRIPLIXAM 10/2.5/5MG
|
PERINDOPRIL ARGININE/INDAPAMIDE/AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
CTD3099
|
TRIPLIXAM 5/1.25/10MG
|
PERINDOPRIL ARGININE/INDAPAMINE/ AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
CTD3097
|
TRIPLIXAM 5/1.25/5MG
|
PERINDOPRIL ARGININE/INDAPAMIDE/AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2019/CTD5016/887ER
|
VIACORAM 3.5/2.5 MG
|
PERINDOPRIL ARGININE / AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2019/CTD5017/888ER
|
VIACORAM 7/5 MG
|
PERINDOPRIL ARGININE / AMLODIPINE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD8017/15701
|
DAFLON 1000 MG
|
MICRONIZED PURIFIED FLAVONOID FRACTION
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2005/221
|
DIAMICRON MR 30MG
|
GLICLAZIDE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
CTD213
|
BI PRETERAX 10/2.5MG
|
PERINDOPRIL ARGININE/INDAPAMIDE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|